[Frequency and stage of relapse after organ-saving combined treatment for urinary bladder cancer].
Urinary bladder cancer relapse was evaluated in 116 patients (stage II--68 (58.6%); stage III--48 (41.3%)). Segmented resection and radiotherapy (STD-- 2 Gy; TTD--40 Gy). Early relapse were registered in 64.0 +/- 7.6% and late one--35.9 +/- 7.6% (stage II early relapse--42.6%; stage III--58.3%). They occurred on primary tumor site in 41.3%; other sites--42.26%. Local relapse was reported in 16.3%. Remission lasted in well-differentiated cell tumors longer than in moderately- or poorly-differentiated ones. Incidence of early relapse in cases of low apoptotic index was relatively higher and vice versa.
Nabruzov
S N
SN
Vakhabov
O U
OU
D000328:Adult; D000368:Aged; D017209:Apoptosis; D015653:Cystectomy / Q000379:methods*; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology* / Q000473:pathology*; D009367:Neoplasm Staging; D018714:Radiotherapy, Adjuvant; D001749:Urinary Bladder Neoplasms / Q000453:epidemiology* / Q000473:pathology* / Q000532:radiotherapy / Q000601:surgery; D014610:Uzbekistan / Q000453:epidemiology; D055815:Young Adult